Alector, Inc. (NASDAQ:ALEC) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Simplywall
2025.05.05 12:32
portai
I'm PortAI, I can summarize articles.

Alector, Inc. (NASDAQ:ALEC) shares have surged 27% in the past month, yet the stock is down 76% over the last year. Despite the recent rebound, the company's price-to-sales (P/S) ratio of 1.3x remains low compared to the biotech industry average of 9.3x. Alector's revenue growth has been disappointing, with a projected decline of 16% per annum over the next three years, contrasting sharply with the industry's expected growth of 157%. This weak outlook contributes to Alector's low P/S ratio, indicating potential challenges ahead for the stock's performance.